Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naïve diabetes obese patients

Diabetes Research and Clinical Practice

Volumn 89, Issue 2, 2010, Pages 110-114

  de Luis, D A ^a   Sagrado, M Gonzalez ^a   Conde, R ^a   Aller, R ^a   Izaola, O ^a   de la Fuente, B ^a   Castrillón, J L Perez ^a   Romero, E ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Cardiovascular risk factors; Diabetes mellitus; Inflammation; Obesity; Resistin

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FAT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; RESISTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; BLOOD; CARDIOVASCULAR DISEASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RESISTIN; RISK FACTORS;

EID: 77955095371     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.03.031     Document Type: Article

References (32)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115:911-919.
2. Meier U., Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin. Chem. Lab. Med. 2004, 50:1511-1525.
3. Matsuda M., Shimomura I., Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 2002, 277:37487-37491.
4. Steppan C.M., Bailey S.T., Bhat S. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
5. Satoh H., Nguyen M.T., Miles P.D., Immamura T., Usui I., Olefsky J.M. Adenovirus-mediated chronic hyper resistinemia leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 2004, 114:224-231.
6. Steppan C.M., Lazar M.A. The current biology of resistin. J. Intern. Med. 2004, 255:439-447.
7. Sato N., Kobayashi K., Inoguchi T., Sonoda N., Immamura M., Sekiguchi N., et al. Adenovirus-mediated high expression of resistin causes dyslipemia in mice. Endocrinology 2005, 146:273-279.
8. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., et al. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 2004, 114:232-239.
9. Pagano C., Marin O., Calcagno A., Schiappelli P., Pilon C., Milan G., et al. Increased serum resistin in adults with Prader Willi syndrome is related to obesity and not to insulin resistance. J. Clin. Endocrinol. Metab. 2005, 90:4335-4340.
10. Burnett M.S., Devaney J.M., Adenika R.J., Lindsay R., Howard B.V. Cross-sectional associations of resistin, coronary heart disease and insulin resistance. J. Clin. Endocrinol. Metab. 2006, 91:64-68.
11. Zou C.C., Liang L., Hong F., Fu J.F., Zhao Z.Y. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr. J. 2005, 52:519-524.
12. Takata Y., Osawa H., Kurokawa M., Yamauchi J., Ochi M., Nishida W. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 2008, 51:534-539.
13. Ellington A., Malik A., Klee G., Turner S., Rule A., Mosley T., et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 2007, 50:708-714.
14. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher Df. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-414.
15. Lukaski H., Johson P.E. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 1985, 4:810-817.
16. Shetty G., Economides P., Horton E., Mantzmoros C., Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450-2454.
17. Azuma K., Katsukawa E., Oguchi S., Murata M., Yamazaki H., Shimada A., et al. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 2003, 11:997-1001.
18. Pfutzner A., Langenfeld M., Kunt T., Lobig M., Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin. Lab. 2003, 49:571-576.
19. Iqbal N., Seshadri P., Stern L., Loh J., Kundu S., Jafar T., et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur. Rev. Med. Pharmacol. Sci. 2005, 9:161-165.
20. Norata G.D., Ongari M., Garlaschelli K., Raselli S., Grigore L., Catapano L. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur. J. Endocrinol. 2007, 156:279-284.
21. Ohmori R., Momiyama Y., Kato R., Taniguchi H., Ogura M., Ayaori M., et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J. Am. Col. Cardiol. 2005, 46:379-380.
22. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939.
23. Kunnari A., Ukkola O., Paivansalo M., Kesaniemi Y.A. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J. Clin. Endocrinol. Metab. 2006, 91:2755-2760.
24. Axelsson J., Bergsten A., Qureshi A.R., Heimburger O., Barany P., Lonnqvist F., et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006, 69:596-604.
25. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 2005, 174:5789-5795.
26. Curat C.A., Wegner V., Sengenes C., Miranville A., Tonus C., Busse R., et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49:744-747.
27. McTernan P.G., McTernan C.L., Chetty R., Jenner K., Fisher F.M., Lauer M.N., et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 2002, 87:2407.
28. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
29. Kunnari A., Ukkola O., Paivansali M., Kesaniemi Y.A. High plasma resistin level is associated with enhanced hsCRP and leucocytes. J. Clin. Endocrinol. Metab. 2006, 91:2755-2760.
30. Bo S., Gambino R., Pagani A., Guidi S., Gentile L., Cassader M., et al. Relationships between human serum resistin inflammatory markers and insulin resistance. Int. J. Obes. 2005, 29:1315-1320.
31. Lehrke M., Reilly M.P., Millingyon S.C., Iqbal N., Rader D.J., Lazar M.A. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med. 2004, 1:e45.
32. Chu N., Kong A.P.S., Kim D.D., AMstrond D., Baxi S., Deustch R., et al. Differential effects of metformin and troglitaznoe on cardiovascular risk factors in patients with DM2. Diabet. Care 2002, 25:542-548.